PhaseV (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- May 16, 2025
- Vertical
- AI/ML-driven clinical development
- Funding URL
- View Funding Page
- Funding Amount:
- $50,000,000
Company Info
- Traction
- PhaseV has delivered results for more than 30 leading pharma/biotech sponsors and CROs.
- Company Description
- PhaseV is developing advanced AI/ML solutions to optimize clinical development. Their platform helps biopharma sponsors and CROs design and execute clinical trials efficiently, analyze data for treatment effects, and inform R&D decisions.
- Market
- Biopharma and CROs
- Location
- Boston, MA, USA
- Coinvestors
- Accel, Insight Partners, Viola Ventures, EXOR, LionBird